Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092142616> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W3092142616 endingPage "715" @default.
- W3092142616 startingPage "712" @default.
- W3092142616 abstract "The study was carried out to evaluate blood biochemical profile following administration of erlotinib, meloxicam and metformin alone and in combination in SCID mice. The mean value of WBC of animal group treated by erlotinib with metformin was significantly increased in comparison to tumor control group. The neutrophil % of tumor control and all treatment groups was considerably high in comparison to normal control, whereas the lymphocyte % and eosinophil % count were decreased in tumor control and treatment group in comparison to normal control. The monocyte % count in animal group treated by metformin alone and in combination with erlotinib was significantly higher than tumor control group. The mean value of creatine kinase (CK) was significantly decreased in animal group treated with meloxicam in comparison to tumor control group. Whereas, the mean value of CK and blood urea nitrogen (BUN) of animal group treated with erlotinib with metformin was significantly increased in comparison to tumor control group. Raised level of BUN in present study might be due to additive damaging effect of metformin and erlotinib on kidney. The mean values of AST, ALT, TB and acid phosphatase of tumor control group were considerably high than normal control group. The mean values of ALP, total bilirubin, creatinine, and acid phosphatase did not alter. In conclusion, administration of erlotinib, meloxicam and metformin in combination alter blood biochemical profile in SCID mice." @default.
- W3092142616 created "2020-10-15" @default.
- W3092142616 creator A5027534407 @default.
- W3092142616 creator A5030062643 @default.
- W3092142616 creator A5052976631 @default.
- W3092142616 creator A5075076623 @default.
- W3092142616 creator A5081859887 @default.
- W3092142616 date "2018-01-01" @default.
- W3092142616 modified "2023-09-23" @default.
- W3092142616 title "Blood biochemical profile following administration of erlotinib, meloxicam and metformin alone and in combination in SCID mice" @default.
- W3092142616 hasPublicationYear "2018" @default.
- W3092142616 type Work @default.
- W3092142616 sameAs 3092142616 @default.
- W3092142616 citedByCount "0" @default.
- W3092142616 crossrefType "journal-article" @default.
- W3092142616 hasAuthorship W3092142616A5027534407 @default.
- W3092142616 hasAuthorship W3092142616A5030062643 @default.
- W3092142616 hasAuthorship W3092142616A5052976631 @default.
- W3092142616 hasAuthorship W3092142616A5075076623 @default.
- W3092142616 hasAuthorship W3092142616A5081859887 @default.
- W3092142616 hasConcept C121608353 @default.
- W3092142616 hasConcept C126322002 @default.
- W3092142616 hasConcept C134018914 @default.
- W3092142616 hasConcept C160160445 @default.
- W3092142616 hasConcept C181199279 @default.
- W3092142616 hasConcept C185592680 @default.
- W3092142616 hasConcept C2778087573 @default.
- W3092142616 hasConcept C2778176769 @default.
- W3092142616 hasConcept C2779438470 @default.
- W3092142616 hasConcept C2779751750 @default.
- W3092142616 hasConcept C2779881121 @default.
- W3092142616 hasConcept C2780306776 @default.
- W3092142616 hasConcept C2780323712 @default.
- W3092142616 hasConcept C55493867 @default.
- W3092142616 hasConcept C555293320 @default.
- W3092142616 hasConcept C71924100 @default.
- W3092142616 hasConcept C98274493 @default.
- W3092142616 hasConceptScore W3092142616C121608353 @default.
- W3092142616 hasConceptScore W3092142616C126322002 @default.
- W3092142616 hasConceptScore W3092142616C134018914 @default.
- W3092142616 hasConceptScore W3092142616C160160445 @default.
- W3092142616 hasConceptScore W3092142616C181199279 @default.
- W3092142616 hasConceptScore W3092142616C185592680 @default.
- W3092142616 hasConceptScore W3092142616C2778087573 @default.
- W3092142616 hasConceptScore W3092142616C2778176769 @default.
- W3092142616 hasConceptScore W3092142616C2779438470 @default.
- W3092142616 hasConceptScore W3092142616C2779751750 @default.
- W3092142616 hasConceptScore W3092142616C2779881121 @default.
- W3092142616 hasConceptScore W3092142616C2780306776 @default.
- W3092142616 hasConceptScore W3092142616C2780323712 @default.
- W3092142616 hasConceptScore W3092142616C55493867 @default.
- W3092142616 hasConceptScore W3092142616C555293320 @default.
- W3092142616 hasConceptScore W3092142616C71924100 @default.
- W3092142616 hasConceptScore W3092142616C98274493 @default.
- W3092142616 hasIssue "10" @default.
- W3092142616 hasLocation W30921426161 @default.
- W3092142616 hasOpenAccess W3092142616 @default.
- W3092142616 hasPrimaryLocation W30921426161 @default.
- W3092142616 hasRelatedWork W1601165976 @default.
- W3092142616 hasRelatedWork W1981045672 @default.
- W3092142616 hasRelatedWork W2004218059 @default.
- W3092142616 hasRelatedWork W2031736098 @default.
- W3092142616 hasRelatedWork W2191688351 @default.
- W3092142616 hasRelatedWork W2275130338 @default.
- W3092142616 hasRelatedWork W2352148140 @default.
- W3092142616 hasRelatedWork W2357982190 @default.
- W3092142616 hasRelatedWork W2363241152 @default.
- W3092142616 hasRelatedWork W2369326608 @default.
- W3092142616 hasRelatedWork W2370696551 @default.
- W3092142616 hasRelatedWork W2379636445 @default.
- W3092142616 hasRelatedWork W2386875529 @default.
- W3092142616 hasRelatedWork W2387118368 @default.
- W3092142616 hasRelatedWork W2391139306 @default.
- W3092142616 hasRelatedWork W2783513915 @default.
- W3092142616 hasRelatedWork W2951486656 @default.
- W3092142616 hasRelatedWork W3024756793 @default.
- W3092142616 hasRelatedWork W3026154172 @default.
- W3092142616 hasRelatedWork W3032652247 @default.
- W3092142616 hasVolume "7" @default.
- W3092142616 isParatext "false" @default.
- W3092142616 isRetracted "false" @default.
- W3092142616 magId "3092142616" @default.
- W3092142616 workType "article" @default.